Correlation Between Sonnet Biotherapeutics and Edesa Biotech
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Edesa Biotech, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Edesa Biotech.
Diversification Opportunities for Sonnet Biotherapeutics and Edesa Biotech
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Sonnet and Edesa is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Edesa Biotech go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Edesa Biotech
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Edesa Biotech. In addition to that, Sonnet Biotherapeutics is 1.7 times more volatile than Edesa Biotech. It trades about -0.11 of its total potential returns per unit of risk. Edesa Biotech is currently generating about -0.09 per unit of volatility. If you would invest 462.00 in Edesa Biotech on August 27, 2024 and sell it today you would lose (245.00) from holding Edesa Biotech or give up 53.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Edesa Biotech
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Edesa Biotech |
Sonnet Biotherapeutics and Edesa Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Edesa Biotech
The main advantage of trading using opposite Sonnet Biotherapeutics and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.| Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. HCW Biologics | Sonnet Biotherapeutics vs. Scpharmaceuticals | Sonnet Biotherapeutics vs. Milestone Pharmaceuticals |
| Edesa Biotech vs. Eliem Therapeutics | Edesa Biotech vs. HCW Biologics | Edesa Biotech vs. Scpharmaceuticals | Edesa Biotech vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |